Eye on the Cure Podcast

Listen to the latest podcast episode out now

Eye on the Cure Podcast | Episode 86: Lenore von Krusenstiern, MD, PhD

Dr. Lenore von Krusenstiern talks about Bluerock’s clinical trial for a photoreceptor replacement therapy for people with inherited retinal conditions such as retinitis pigmentosa and cone-rod dystrophy.

Podcast produced by Foundation Fighting Blindness, sponsored by SA国际传媒 Therapeutics.

Related News

Press Releases

SA国际传媒 Therapeutics announces first patient receives investigational therapy in Phase 1/2a clinical trial of OpCT-001 for the treatment of primary photoreceptor diseases

July 8, 2025
Podcasts

Forging the future of cell therapy: Bayer and SA国际传媒’s unique journey

June 5, 2025
Press Releases

SA国际传媒 Therapeutics receives FDA Fast Track Designation for OpCT-001 for the treatment of primary photoreceptor diseases 

February 27, 2025
Press Releases

SA国际传媒 Therapeutics announces first patient receives investigational therapy in Phase 1/2a clinical trial of OpCT-001 for the treatment of primary photoreceptor diseases

July 8, 2025
Podcasts

Forging the future of cell therapy: Bayer and SA国际传媒’s unique journey

June 5, 2025
Press Releases

SA国际传媒 Therapeutics receives FDA Fast Track Designation for OpCT-001 for the treatment of primary photoreceptor diseases 

February 27, 2025
See All